ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 143 filers reported holding ENDOCYTE INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,057,000 | +21.8% | 59,497 | -5.4% | 0.00% | 0.0% |
| Q2 2018 | $868,000 | +682.0% | 62,865 | +45.3% | 0.00% | – |
| Q1 2017 | $111,000 | +1.8% | 43,259 | +1.3% | 0.00% | – |
| Q4 2016 | $109,000 | -20.4% | 42,706 | -3.9% | 0.00% | – |
| Q3 2016 | $137,000 | -2.8% | 44,437 | +0.9% | 0.00% | – |
| Q2 2016 | $141,000 | -22.5% | 44,037 | -25.1% | 0.00% | -100.0% |
| Q1 2016 | $182,000 | -15.0% | 58,775 | +9.9% | 0.00% | 0.0% |
| Q4 2015 | $214,000 | -5.3% | 53,465 | +8.6% | 0.00% | 0.0% |
| Q3 2015 | $226,000 | -6.6% | 49,250 | +5.8% | 0.00% | 0.0% |
| Q2 2015 | $242,000 | +4.8% | 46,535 | +26.4% | 0.00% | 0.0% |
| Q1 2015 | $231,000 | +18.5% | 36,825 | +19.1% | 0.00% | 0.0% |
| Q4 2014 | $195,000 | +6.6% | 30,925 | +3.0% | 0.00% | 0.0% |
| Q3 2014 | $183,000 | -11.2% | 30,025 | -3.8% | 0.00% | 0.0% |
| Q2 2014 | $206,000 | -68.4% | 31,225 | +14.1% | 0.00% | -50.0% |
| Q1 2014 | $652,000 | +111.0% | 27,374 | -5.2% | 0.00% | +100.0% |
| Q4 2013 | $309,000 | -19.7% | 28,864 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $385,000 | +0.8% | 28,864 | -0.9% | 0.00% | 0.0% |
| Q2 2013 | $382,000 | – | 29,131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|